2020 Global Pharma Study
Fill in your details to receive this year’s report on the global reputation study of the pharmaceutical industry conducted by Caliber. The report includes a comprehensive analysis of public perceptions of pharma companies across 17 leading economies, with insights around trust levels and drivers of stakeholder behavior, as well as changing expectations as result of the COVID crisis.
- 67 biggest pharmaceutical companies
- 17 countries (Brazil, Canada, China, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, UK, USA)
- Key corporate brand, reputation and behavioral indicators
- Commentary and conclusions on the future reputation of the sector